Medtronic plc (MDT)
Health Care / Health Care Equipment
S&P 500$77.59
Below average on several measures. Research carefully.
Weak
Score based on 4 of 5 models — moderate confidence
Is Medtronic plc a Good Investment in 2026?
Medtronic plc (MDT) scores 4.2 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Medtronic plc as Strong (7/9). The Graham model is the least favorable, rating it Neutral. Medtronic plc currently trades below its estimated fair value of $87, suggesting potential upside. Medtronic plc ranks #785 out of 1126 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading below fair value estimate. EPS grew 31% last year.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
41% above fair value
Lynch
Attractive
Growth rate vs price (PEG)
Greenblatt
Attractive
Top half (rank 33%)
Frequently Asked Questions
Is Medtronic plc (MDT) a good investment?
What is Medtronic plc's Piotroski F-Score?
Is MDT overvalued or undervalued?
How does MDT compare to other Health Care stocks?
What do investment models say about MDT?
Similar Stocks
Compare MDT with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer